Cero Therapeutics Holdings, Inc.
Biotechnology company · South San Francisco, California, United States · OTC: CERO
Cero Therapeutics Holdings, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2021. Its shares trade on OTC under the ticker CERO. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2025.
Cero Therapeutics Holdings at a glance
What does Cero Therapeutics Holdings do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $5 million sold (2025).
Frequently asked questions about Cero Therapeutics Holdings
Where is Cero Therapeutics Holdings headquartered?
Cero Therapeutics Holdings, Inc. is headquartered in South San Francisco, California, United States.
What does Cero Therapeutics Holdings do?
Cero Therapeutics Holdings, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Cero Therapeutics Holdings a public company?
Yes. Cero Therapeutics Holdings, Inc. trades on OTC under the ticker CERO.
When was Cero Therapeutics Holdings founded?
The earliest incorporation on record for Cero Therapeutics Holdings, Inc. is in 2021, according to public company registers.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences